Ellen S. de Morrée

713 total citations
10 papers, 544 citations indexed

About

Ellen S. de Morrée is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ellen S. de Morrée has authored 10 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Ellen S. de Morrée's work include Prostate Cancer Treatment and Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Estrogen and related hormone effects (2 papers). Ellen S. de Morrée is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Estrogen and related hormone effects (2 papers). Ellen S. de Morrée collaborates with scholars based in Netherlands, United States and Canada. Ellen S. de Morrée's co-authors include Ronald de Wit, Robert J. van Soest, Ron H.J. Mathijssen, Wytske M. van Weerden, Erik A.C. Wiemer, Martin E. van Royen, Wilma J. Teubel, Majorie B.M. van Duursen, Sandra M. Nijmeijer and Corrina M.A. de Ridder and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Urology.

In The Last Decade

Ellen S. de Morrée

10 papers receiving 536 citations

Peers

Ellen S. de Morrée
Emilda Thompson United Kingdom
Shivang Doshi United States
Gal Maier United Kingdom
Semini Sumanasuriya United Kingdom
Oliver Sartor United States
K. N. Canada
Avery Spitz United States
L A Speicher United States
Renee Lester Canada
Dan Brigham
Emilda Thompson United Kingdom
Ellen S. de Morrée
Citations per year, relative to Ellen S. de Morrée Ellen S. de Morrée (= 1×) peers Emilda Thompson

Countries citing papers authored by Ellen S. de Morrée

Since Specialization
Citations

This map shows the geographic impact of Ellen S. de Morrée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen S. de Morrée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen S. de Morrée more than expected).

Fields of papers citing papers by Ellen S. de Morrée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen S. de Morrée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen S. de Morrée. The network helps show where Ellen S. de Morrée may publish in the future.

Co-authorship network of co-authors of Ellen S. de Morrée

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen S. de Morrée. A scholar is included among the top collaborators of Ellen S. de Morrée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen S. de Morrée. Ellen S. de Morrée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Morrée, Ellen S. de, René Böttcher, Robert J. van Soest, et al.. (2016). Loss of SLCO1B3 drives taxane resistance in prostate cancer. British Journal of Cancer. 115(6). 674–681. 51 indexed citations
2.
Soest, Robert J. van, Annemieke J.M. Nieuweboer, Ellen S. de Morrée, et al.. (2015). The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 51(17). 2562–2569. 47 indexed citations
3.
Nieuweboer, Annemieke J.M., Ellen S. de Morrée, Anne‐Joy M. de Graan, et al.. (2015). Inter-patient variability in docetaxel pharmacokinetics: A review. Cancer Treatment Reviews. 41(7). 605–613. 41 indexed citations
4.
Soest, Robert J. van, Ellen S. de Morrée, Charlotte F. Kweldam, et al.. (2014). Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer. European Urology. 67(6). 981–985. 96 indexed citations
5.
Wissing, Michel D., Ellen S. de Morrée, Vincent O. Dezentjé, et al.. (2014). Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness. Oncotarget. 5(17). 7357–7367. 23 indexed citations
6.
Soest, Robert J. van, Ellen S. de Morrée, Corrina M.A. de Ridder, et al.. (2014). The in vivo efficacy of docetaxel and cabazitaxel in a cell-line based xenograft of castration-resistant prostate cancer (CRPC) previously treated with enzalutamide.. Journal of Clinical Oncology. 32(15_suppl). 5046–5046. 1 indexed citations
7.
Soest, Robert J. van, Ellen S. de Morrée, Liji Shen, et al.. (2013). Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study. European Urology. 66(2). 330–336. 45 indexed citations
8.
Soest, Robert J. van, Martin E. van Royen, Ellen S. de Morrée, et al.. (2013). Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer. European Journal of Cancer. 49(18). 3821–3830. 175 indexed citations
9.
Soest, Robert J. van, Martin E. van Royen, Ellen S. de Morrée, et al.. (2013). Effects on androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone, and enzalutamide: Potential mechanism for cross-resistance in castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 31(15_suppl). 5064–5064. 4 indexed citations
10.
Duursen, Majorie B.M. van, Sandra M. Nijmeijer, Ellen S. de Morrée, Paul C. de Jong, & Martin van den Berg. (2011). Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology. 289(2-3). 67–73. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilda Thompson Breakdown of academic impact, for papers by Shivang Doshi Breakdown of academic impact, for papers by Gal Maier Breakdown of academic impact, for papers by Semini Sumanasuriya Breakdown of academic impact, for papers by Oliver Sartor Breakdown of academic impact, for papers by K. N. Breakdown of academic impact, for papers by Avery Spitz Breakdown of academic impact, for papers by L A Speicher Breakdown of academic impact, for papers by Renee Lester Breakdown of academic impact, for papers by Dan Brigham
Rankless by CCL
2026